Literature DB >> 33404583

PASCAR commentary on the International Society of Hypertension global guidelines 2020: relevance to sub-Saharan Africa.

E S Jones1, Albertino Damasceno2, Elijah N Ogola3, Dike B Ojji4, Anastase Dzudie5, B L Rayner6.   

Abstract

Hypertension guidelines have been based on country-specific data until the publication of the International Society of Hypertension (ISH) global guidelines. The major differences between the ISH global guidelines and other international guidelines are the stratified recommendations to accommodate differences in available resources between countries and within countries. This is a key and novel proposal in the new ISH guidelines. There is the separation of optimal versus essential criteria for diagnosis and treatment according to availability of resources. This guideline includes recommendations for sub-Saharan Africa. The Pan-African Society of Cardiology (PASCAR) continues to promote awareness and recommendations on hypertension in Africa. This commentary provides a summary and discussion of the global guidelines in order to clarify the position of PASCAR.

Entities:  

Mesh:

Year:  2020        PMID: 33404583      PMCID: PMC8762770          DOI: 10.5830/CVJA-2020-055

Source DB:  PubMed          Journal:  Cardiovasc J Afr        ISSN: 1015-9657            Impact factor:   1.167


  24 in total

1.  Prices of antihypertensive medicines in sub-Saharan Africa and alignment to WHO's model list of essential medicines.

Authors:  Marc Twagirumukiza; Lieven Annemans; Jan G Kips; Emile Bienvenu; Luc M Van Bortel
Journal:  Trop Med Int Health       Date:  2010-01-11       Impact factor: 2.622

Review 2.  Salt reduction in the United Kingdom: a successful experiment in public health.

Authors:  F J He; H C Brinsden; G A MacGregor
Journal:  J Hum Hypertens       Date:  2013-10-31       Impact factor: 3.012

3.  Comparison of Dual Therapies for Lowering Blood Pressure in Black Africans.

Authors:  Dike B Ojji; Bongani Mayosi; Veronica Francis; Motasim Badri; Victoria Cornelius; Wynand Smythe; Nicky Kramer; Felix Barasa; Albertino Damasceno; Anastase Dzudie; Erika Jones; Charles Mondo; Okechukwu Ogah; Elijah Ogola; Mahmoud U Sani; Gabriel L Shedul; Grace Shedul; Brian Rayner; Ikechi G Okpechi; Karen Sliwa; Neil Poulter
Journal:  N Engl J Med       Date:  2019-03-18       Impact factor: 91.245

4.  Potential US Population Impact of the 2017 ACC/AHA High Blood Pressure Guideline.

Authors:  Paul Muntner; Robert M Carey; Samuel Gidding; Daniel W Jones; Sandra J Taler; Jackson T Wright; Paul K Whelton
Journal:  Circulation       Date:  2017-11-13       Impact factor: 29.690

5.  Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

Authors: 
Journal:  JAMA       Date:  2002-12-18       Impact factor: 56.272

6.  2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

Authors:  Paul A James; Suzanne Oparil; Barry L Carter; William C Cushman; Cheryl Dennison-Himmelfarb; Joel Handler; Daniel T Lackland; Michael L LeFevre; Thomas D MacKenzie; Olugbenga Ogedegbe; Sidney C Smith; Laura P Svetkey; Sandra J Taler; Raymond R Townsend; Jackson T Wright; Andrew S Narva; Eduardo Ortiz
Journal:  JAMA       Date:  2014-02-05       Impact factor: 56.272

7.  Recent advances in hypertension in sub-Saharan Africa.

Authors:  Okechukwu S Ogah; Brian L Rayner
Journal:  Heart       Date:  2013-05-24       Impact factor: 5.994

Review 8.  Burden of undiagnosed hypertension in sub-saharan Africa: a systematic review and meta-analysis.

Authors:  Feven Ataklte; Sebhat Erqou; Stephen Kaptoge; Betiglu Taye; Justin B Echouffo-Tcheugui; Andre P Kengne
Journal:  Hypertension       Date:  2014-11-10       Impact factor: 10.190

9.  Hypertension in sub-Saharan Africa: cross-sectional surveys in four rural and urban communities.

Authors:  Marleen E Hendriks; Ferdinand W N M Wit; Marijke T L Roos; Lizzy M Brewster; Tanimola M Akande; Ingrid H de Beer; Sayoki G Mfinanga; Amos M Kahwa; Peter Gatongi; Gert Van Rooy; Wendy Janssens; Judith Lammers; Berber Kramer; Igna Bonfrer; Esegiel Gaeb; Jacques van der Gaag; Tobias F Rinke de Wit; Joep M A Lange; Constance Schultsz
Journal:  PLoS One       Date:  2012-03-12       Impact factor: 3.240

Review 10.  HIV, drugs and the kidney.

Authors:  Nicola Wearne; Bianca Davidson; Marc Blockman; Annoesjka Swart; Erika Sw Jones
Journal:  Drugs Context       Date:  2020-03-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.